4 years ago

Sphere Fluidics Secures $40 Million to Advance Single-Cell Analysis Technology

  • Cambridge-based medtech startup Sphere Fluidics has raised $40 million in a funding round led by Sofinnova Partners and Redmile Group

  • The company will use the funds to expand its international sales activities, improve customer support, and further develop its product research and development programs, including novel applications for its Cyto-Mine Single Cell Analysis System.

      • ProblemHealthcare

      "Drug discovery and cell therapy research are slow and expensive, requiring analysis of millions of individual cells to identify rare and valuable ones."

      Solution

      "Sphere Fluidics' Cyto-Mine platform automates single-cell analysis, making it faster, cheaper, and more efficient to identify and isolate rare cells for drug discovery and cell therapy development."

      Covered on